CrossrefInfokarte
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E36
DOI: 10.3816/clm.2009.n.098 ↗Abstract
Kein Abstract verfügbar.
EUVIMED